Exact Mass: 486.2829

Exact Mass Matches: 486.2829

Found 37 metabolites which its exact mass value is equals to given mass value 486.2829, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

DG(2:0/6 keto-PGF1alpha/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoic acid

C25H42O9 (486.2829)


DG(2:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(6 keto-PGF1alpha/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoic acid

C25H42O9 (486.2829)


DG(6 keto-PGF1alpha/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/6 keto-PGF1alpha)

(2R)-3-(Acetyloxy)-2-hydroxypropyl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoic acid

C25H42O9 (486.2829)


DG(2:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(6 keto-PGF1alpha/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoic acid

C25H42O9 (486.2829)


DG(6 keto-PGF1alpha/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/TXB2/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

C25H42O9 (486.2829)


DG(2:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(TXB2/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

C25H42O9 (486.2829)


DG(TXB2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/TXB2)

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

C25H42O9 (486.2829)


DG(2:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(TXB2/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

C25H42O9 (486.2829)


DG(TXB2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

10,11-Dihydro-12-hydroxynerolidol 3-O-beta-D-2-acetylglucoside

10,11-Dihydro-12-hydroxynerolidol 3-O-beta-D-2-acetylglucoside

C25H42O9 (486.2829)


   

2-Deacetoxytaxinine B

2-Deacetoxytaxinine B

C25H42O9 (486.2829)


   

MGMG 16:3

1-(7Z,10Z,13Z-hexadecatrienoyl)-3-O-beta-D-galactosyl-sn-glycerol

C25H42O9 (486.2829)


Annotation level-3

   

14beta-O-(2S,3R-nilyl)rhodomollein XVIII

14beta-O-(2S,3R-nilyl)rhodomollein XVIII

C25H42O9 (486.2829)


   

(2S)-1-O-((7Z,10Z,13Z)-hexadecatrienoyl)-3-O-beta-D-galactopyranosylglycerol|(2S)-1-O-(7Z,10Z,13Z-hexadecatrienoyl)-3-O-beta-galactopyranosylglycerol

(2S)-1-O-((7Z,10Z,13Z)-hexadecatrienoyl)-3-O-beta-D-galactopyranosylglycerol|(2S)-1-O-(7Z,10Z,13Z-hexadecatrienoyl)-3-O-beta-galactopyranosylglycerol

C25H42O9 (486.2829)


   

(-)-Bis-(3-acetoxyundec-5-enyl)disulfid

(-)-Bis-(3-acetoxyundec-5-enyl)disulfid

C26H46O4S2 (486.2837)


   

Gaudichaudioside C

Gaudichaudioside C

C25H42O9 (486.2829)


   

peloruside C

peloruside C

C25H42O9 (486.2829)


   

Marinolic acid A

Marinolic acid A

C25H42O9 (486.2829)


   

DG(2:0/6 keto-PGF1alpha/0:0)

DG(2:0/6 keto-PGF1alpha/0:0)

C25H42O9 (486.2829)


   

DG(6 keto-PGF1alpha/2:0/0:0)

DG(6 keto-PGF1alpha/2:0/0:0)

C25H42O9 (486.2829)


   

DG(2:0/0:0/6 keto-PGF1alpha)

DG(2:0/0:0/6 keto-PGF1alpha)

C25H42O9 (486.2829)


   

DG(6 keto-PGF1alpha/0:0/2:0)

DG(6 keto-PGF1alpha/0:0/2:0)

C25H42O9 (486.2829)


   

DG(2:0/TXB2/0:0)

DG(2:0/TXB2/0:0)

C25H42O9 (486.2829)


   

DG(TXB2/2:0/0:0)

DG(TXB2/2:0/0:0)

C25H42O9 (486.2829)


   

DG(2:0/0:0/TXB2)

DG(2:0/0:0/TXB2)

C25H42O9 (486.2829)


   

DG(TXB2/0:0/2:0)

DG(TXB2/0:0/2:0)

C25H42O9 (486.2829)


   

2-(7Z,10Z,13Z)-hexadecatrienoyl-3-(beta-D-galactosyl)-sn-glycerol

2-(7Z,10Z,13Z)-hexadecatrienoyl-3-(beta-D-galactosyl)-sn-glycerol

C25H42O9 (486.2829)


   

[1-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,10E,13E)-hexadeca-7,10,13-trienoate

[1-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,10E,13E)-hexadeca-7,10,13-trienoate

C25H42O9 (486.2829)


   

ST 19:0;O4;Hex

ST 19:0;O4;Hex

C25H42O9 (486.2829)


   

[5-(acetyloxy)-3,4-dihydroxy-6-[(12-hydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl)oxy]oxan-2-yl]methyl acetate

[5-(acetyloxy)-3,4-dihydroxy-6-[(12-hydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl)oxy]oxan-2-yl]methyl acetate

C25H42O9 (486.2829)


   

2-{[6-hydroxy-4-(5-hydroxy-3-methylpent-3-en-1-yl)-3,8-bis(hydroxymethyl)-4a,8-dimethyl-1,2,5,6,7,8a-hexahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

2-{[6-hydroxy-4-(5-hydroxy-3-methylpent-3-en-1-yl)-3,8-bis(hydroxymethyl)-4a,8-dimethyl-1,2,5,6,7,8a-hexahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

C25H42O9 (486.2829)


   

3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl 3-hydroxy-2-methylbutanoate

3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl 3-hydroxy-2-methylbutanoate

C25H42O9 (486.2829)


   

[(2r,3s,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-{[(3s,6e,11s)-12-hydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}oxan-2-yl]methyl acetate

[(2r,3s,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-{[(3s,6e,11s)-12-hydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}oxan-2-yl]methyl acetate

C25H42O9 (486.2829)


   

(2s,3r,4s,5s)-2-{[(1s,4as,6r,8s,8ar)-6-hydroxy-4-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-3,8-bis(hydroxymethyl)-4a,8-dimethyl-1,2,5,6,7,8a-hexahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5s)-2-{[(1s,4as,6r,8s,8ar)-6-hydroxy-4-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-3,8-bis(hydroxymethyl)-4a,8-dimethyl-1,2,5,6,7,8a-hexahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

C25H42O9 (486.2829)


   

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2s,3s)-3-hydroxy-2-methylbutanoate

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2s,3s)-3-hydroxy-2-methylbutanoate

C25H42O9 (486.2829)


   

(1r,3s,4r,6s,7r,8r,9s,10s,13s,14s,16s)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2r,3s)-3-hydroxy-2-methylbutanoate

(1r,3s,4r,6s,7r,8r,9s,10s,13s,14s,16s)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2r,3s)-3-hydroxy-2-methylbutanoate

C25H42O9 (486.2829)


   

[(2r,3s,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-{[(3s,6e,11r)-12-hydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}oxan-2-yl]methyl acetate

[(2r,3s,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-{[(3s,6e,11r)-12-hydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}oxan-2-yl]methyl acetate

C25H42O9 (486.2829)